Differential expression of proteins with heparin affinity in patients with rheumatoid and psoriatic arthritis: A preliminary study

Clinical and Experimental Rheumatology

Volumn 31, Issue 5, 2013, Pages 665-671

  Grazio, Simeon ^a   Razdorov, Genadij ^b   Erjavec, Igor ^b   Grubisic, Frane ^a   Kusic, Zvonko ^a   Punda, Marija ^a   Anticevic, Darko ^c   Vukicevic, Slobodan ^b   Grgurevic, Lovorka ^b  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c KBC Zagreb   (Croatia)

Author keywords

Liquid chromatography; Mass spectrometry; Proteomics; Psoriatic arthritis; Rheumatoid arthritis

Indexed keywords

BLOOD CLOTTING FACTOR 9; COMPLEMENT COMPONENT C8B; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEPARIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN J CHAIN; INTER ALPHA TRYPSIN INHIBITOR; PREDNISOLONE;

ADULT; AGED; ARTHRITIS; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOWN REGULATION; DRUG PROTEIN BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; NON INFLAMMATORY ARTHRITIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEOMICS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; TANDEM MASS SPECTROMETRY; UPREGULATION;

ADULT; AGED; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BLOOD PROTEINS; CHROMATOGRAPHY, AFFINITY; DATABASES, PROTEIN; HEPARIN; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEIN BINDING; PROTEOMICS; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84884941240     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. GLADMAN D, ANTONI C, MEASE P et al. Psoriatic arthritis: epidemiology, clinical features, course and outcome. Ann Rheum Dis 2005; 64 (Suppl. 2): ii14-7.
2. HELLIWELL P, TAYLOR W: Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 2005; 64 (Suppl. 2): ii3-ii8.
3. SMOLEN JS, ALETAHA D, STEINER G: Does damage cause inflammation? Revisiting the link between joint damage and inflammation. Ann Rheum Dis 2009; 68: 159-62.
4. RHODES B, FüRNROHR BG, VYSE TJ: C-reactive protein in rheumatology: biology and genetics. Nat Rev Rheumatol 2011; 7: 282-9.
5. RAZA K, BREESE M, NIGHTINGALE P, et al: Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol 2005; 32: 231-8.
6. MOURA RA, CASCãO R, PERPéTUO I, et al: Spondyloarthritis and rheumatoid arthritis: different clinical manifestations, similar cytokine network. Ann Rheum Dis 2011; 70: A82-3.
7. RIEDMANN JP, MUNOZ S, KAVANAUGH A: The use of second generation anti-CCP antibody (anti-CCP2) testing in rheumatoid arthritis - a systematic review. Clin Exp Rheumatol 2005; 23 (Suppl. 39): S69-76.
8. RöNNELID J, WICK MC, LAMPA J, et al: Longitudinal analysis of citrullinated protein/ peptide antibodies anti-CP) during 5 year follow up in early rheumatoid arthritis: anti- CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 2005; 64: 1744-9.
9. GRGUREVIC L, MACEK B, DURDEVIC D, VUKICEVIC S: Detection of bone and cartilage- related proteins in plasma of patients with a bone fracture using liquid chromatography- mass spectrometry. Int Orthop 2007; 31: 743-51.
10. GRGUREVIC L, MACEK B, HEALY DR, et al: Circulating bone morphogenetic protein 1-3 isoform increases renal fibrosis. J Am Soc Nephrol 2011; 21: 681-92.
11. World Health Organization. Declaration of Helsinki: BMJ 1996; 313: 1448-9.
12. STICH TM: Determination of protein covalently bound to agarose supports using bicinchoninic acid. Anal Biochem 1990 Dec; 191: 343-6.
13. SHEVCHENKO A, TOMAS H, HAVLIS J, et al: In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 2006; 1: 2856-60.
14. MAIOLICA A, CITTARO D, BORSOTTI D, et al: Structural analysis of multiprotein complexes by cross-linking, mass spectrometry, and database searching. Mol Cell Proteomics 2007; 6: 2200-11.
15. GATLIN CL, KLEEMANN GR, HAYS LG, et al: Protein identification at the low femtomole level from silver-stained gels using a new fritless electrospray interface for liquid chromatography-microspray and nanospray mass spectrometry. Anal Biochem 1998; 263: 93-101.
16. ISHIHAMA Y, RAPPSILBER J, ANDERSEN JS, et al: Microcolumns with self-assembled particle frits for proteomics. J Chromatogr A 2002; 979: 233-9.
17. COX J, MANN M: MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteomewide protein quantification. Nat Biotechnol 2008; 26: 1367-72.
18. COX J, NEUHAUSER N, MICHALSKI A, et al: Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 2011; 10: 1794-805.
19. LUBER CA, COX J, LAUTERBACH H, et al: Quantitative Proteomics Reveals Subset- Specific Viral Recognition in Dendritic Cells. Immunity 2010; 32: 279-89.
20. BOEUF S, STECK E, PELTTARI K, et al: Subtractive gene expression profiling of articular cartilage and mesenchymal stem cells: serpins as cartilage-relevant differentiation markers. Osteoarthritis Cartilage 2008; 16: 48-60.
21. SILVERMAN GA, BIRD PI, CARRELL RW, et al: The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 2001; 276: 33293-6.
22. SILVERMAN GA, WHISSTOCK JC, ASKEW DJ, et al: Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis. Cell Mol Life Sci 2004; 61: 301-25.
23. BENZ K, BREIT S, LUKOSCHEK M, et al: Molecular analysis of expansion, differentiation, and growth factor treatment of human chondrocytes identifies differentiation markers and growth-related genes. Biochem Biophys Res Commun 2002; 293: 284-92.
24. BOGLIOLO L, CREPALDI G, CAPORALI R: Biomarkers and prognostic stratification in psoriatic arthritis. Reumatismo 2012; 64: 88- 98.
25. GRGUREVIC L, MACEK B, VUKICEVIC S: Blood biomarkers for bone fracture and cartilage injury. US 8182998 B2 2012.
26. STECK E, BRäUN J, PELTTARI K, et al: Chondrocyte secreted CRTAC1: a glycosylated extracellular matrix molecule of human articular cartilage. Matrix Biol 2007; 26: 30-41.
27. JASIN HE, COOKE TD: The inflammatory role of immune complexes trapped in joint collagenous tissues. Clin Exp Immunol 1978; 33: 416-24.
28. BRODEUR JP, RUDDY S, SCHWARTZ LB, et al: Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis. Arthritis Rheum 1991; 34: 1531-7.
29. HOGASEN K, MOLLNES TE, HARBOE M, et al: Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluid. J Rheumatol 1995; 22: 24-8.
30. CHIMENTI MS, PERRICONE C, GRACEFFA D, et al: Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. Clin Exp Rheumatol 2012; 30: 23-30.
31. McRAE JL, COWAN PJ, POWER DA, et al: Human factor H-related protein 5 (FHR-5). A new complement-associated protein. J Biol Chem 2001; 276: 6747-54.
32. FRIESE MA, MANUELIAN T, JUNNIKKALA S, et al: Release of endogenous anti-inflammatory complement regulators FHL-1 and factor H protects synovial fibroblasts during rheumatoid arthritis. Clin Exp Immunol 2003; 132: 485-95.
33. McRAE JL, DUTHY TG, GRIGGS KM, et al: Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein. J Immunol 2005; 174: 6250-6.
34. SATTAR N, McCAREY DW, CAPELL H, et al: Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003; 108: 2957-63.
35. PAMUK GE, VURAL O, TURGUT B, et al: Increased platelet activation markers in rheumatoid arthritis: are they related with subclinical atherosclerosis. Platelets 2008; 19: 146-54.
36. SO AK, VARISCO PA, KEMKES-MATTHES B, et al: Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J Thromb Haemost 2003; 1: 2510-5.
37. McENTEGART A, CAPELL HA, CRERAN D, et al: Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) 2001; 40: 640-4.
38. UNDAS A, GISSEL M, KWASNY-KROCHIN B, et al: Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition. Thromb Haemost 2010; 104: 224-30.
39. LAU CS, McLAREN M, HANSLIP J, et al: Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis. Ann Rheum Dis 1993; 52: 643-9.
40. Di MINNO MN, IERVOLINO S, PELUSO R, et al: Platelet reactivity and disease activity in subjects with psoriatic arthritis. J Rheumatol 2012; 39: 334-6.